Dr Day has a particular interest, and wide experience of working in the field of orphan products.

He was lead author for the CHMP Guidance document on Clinical Trials in Small Populations

He helped develop the FDA–NIH course on the Science of Small Clinical Trials
and has been a key presenter each year it has run.

He has successfully helped companies through regulatory approvals of several orphan products in the US and Europe.

Go to top